HWI pharma services GmbH

The HWI Group is a family-owned, independent service partner in the pharma and biotech sector, offering a portfolio ranging from formulation and analytical development and quality control to manufacturing of clinical and smaller market batches, pre-clinical development, pharmacovigilance and GxP services. Its technology platform for parenteral, nasal and oral applications focuses on developing innovative, affordable drugs for poorly soluble small and large molecules, with more than 35 years of experience and 150 colleagues across 3 sites in Germany.